pubmed.ncbi.nlm.nih.gov

Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis - PubMed

Meta-Analysis

. 2017 Nov;76(9):789-797.

doi: 10.1007/s00393-016-0172-5.

Affiliations

Meta-Analysis

Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis

Y H Lee et al. Z Rheumatol. 2017 Nov.

Abstract

Objective: We aimed to evaluate the relationship between circulating blood adipokine levels and systemic sclerosis (SSc).

Methods: We conducted a meta-analysis on serum/plasma adiponectin, leptin, or resistin levels in patients with SSc and controls, and performed a subgroup analysis based on ethnicity and/or disease type.

Results: Eleven studies (511 patients with SSc and 341 controls) were included in the meta-analysis. Meta-analysis revealed that adiponectin levels were significantly lower in patients with SSc than in controls (standardized mean differences [SMD] = -0.638; 95 % confidence intervals [CI] = -1.154, -0.122; P = 0.015). Stratification by ethnicity showed a low adiponectin level associated with SSc in Caucasians (SMD = -0.439; 95 % CI = -1.092, -0.213; P = 0.187) and Asians (SMD = -1.006; 95 % CI = -2.031, -0.019; P = 0.055), although this result was not statistically significant. Stratification by disease type revealed that the adiponectin level was significantly lower in the diffuse SSc, but not limited SSc, group than in the control (diffuse: SMD = -1.445; 95 % CI = -2.276, -0.614; P = 0.001; limited: SMD = 0.188; 95 % CI = -0.064, 0.439; P = 0.144). Meta-analysis showed no association between leptin levels and SSc (SMD = -0.029; 95 % CI = -1.362, 1.304; P = 0.966), and no association between resistin levels and SSc (SMD = 0.202; 95 % CI = -0.091, 0.496; P = 0.177).

Conclusions: Our meta-analysis revealed a significantly lower circulating adiponectin level in patients with SSc than in controls. This difference was apparent in the diffuse type of SSc, but not in the limited type. However, circulating leptin and resistin levels were not different between patients with SSc and healthy controls.

Keywords: Adipokines; Level; Scleroderma; Systemic sclerosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Rheumatol Int. 2007 Jul;27(9):827-33 - PubMed
    1. Arthritis Res Ther. 2012 Oct 23;14(5):R229 - PubMed
    1. Exp Dermatol. 2011 Sep;20(9):764-6 - PubMed
    1. Ann Intern Med. 2010 Jan 19;152(2):93-100 - PubMed
    1. Biofactors. 2011 Nov-Dec;37(6):413-20 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources